LT - Janus kinazės inhibitoriaus (R)-3-(4-(7H-pirol[2,3-d]pirimidin-4-il)-1H-pirazol-1-il)-3-ciklopentilpropannitrilo druskų panaudojimas
EN - USE OF SALTS OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-1H- PYRAZOL-1-YL)-3- CYCLOPENTYLPROPANENITRILE
Legal status
Patent revoked (after opposition at EPO)
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
A61K 9/00 |
(2006.01) |
|
|
A61K 9/20 |
(2006.01) |
|
|
C07D 487/04 |
(2006.01) |
|
|
A61K 31/519 |
(2006.01) |
European patent
| (11) |
Number of the document |
3070090 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
16152794.0 |
|
Date of filing the European patent application |
2008-06-12 |
| (97) |
Date of publication of the European application |
2016-09-21 |
| (45) |
Date of publication and mention of the grant of the patent |
2018-12-12
|
| (46) |
Date of publication of the claims translation |
2019-06-25
|
Priority applications
| (30) |
Number |
Date |
Country code |
|
943705 P |
2007-06-13
|
US |
Inventors
| (72) |
LI, Hui-Yin, US
RODGERS, James, D., US
|
Grantee
| (73) |
Incyte Holdings Corporation,
1801 Augustine Cut-Off, Wilmington, DE 19803,
US
|
Attorney or representative
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
Title
| (54) |
Janus kinazės inhibitoriaus (R)-3-(4-(7H-pirol[2,3-d]pirimidin-4-il)-1H-pirazol-1-il)-3-ciklopentilpropannitrilo druskų panaudojimas |
| |
USE OF SALTS OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-1H- PYRAZOL-1-YL)-3- CYCLOPENTYLPROPANENITRILE |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2021-05-18 |
14 |
289.00
EUR
|
Legal status
|
Patent revoked (after opposition at EPO)
|
|
|
Invalidation date |
2021-08-23 |
